|
Market Closed -
Nasdaq Stockholm
17:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 163.20 SEK | -1.09% |
|
+1.12% | +3.82% |
| 09-15 | Cellavision's newly appointed CEO Stephen Ferguson makes his first share purchase for SEK 1.3m | FW |
| 09-14 | Lannebo Hälsa och Ny Teknik rose 5.9% in August, Bico among the month's winners | FW |
Company Valuation: CellaVision AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,757 | 5,462 | 5,057 | 5,188 | 3,749 | 3,893 | - | - |
| Change | - | -29.58% | -7.42% | 2.59% | -27.72% | 3.82% | - | - |
| Enterprise Value (EV) 1 | 7,763 | 5,456 | 5,000 | 5,065 | 3,587 | 3,705 | 3,671 | 3,614 |
| Change | - | -29.71% | -8.37% | 1.31% | -29.18% | 3.29% | -0.93% | -1.54% |
| P/E | 61.9x | 46.2x | 38.8x | 36.9x | 24.5x | 28x | 22.3x | 19.7x |
| PBR | 14.3x | 8.51x | 7.06x | 6.36x | 4.22x | 4.03x | 3.65x | 3.28x |
| PEG | - | -8.36x | 3.8x | 4.58x | 2.78x | -3.05x | 0.9x | 1.5x |
| Capitalization / Revenue | 13.7x | 8.54x | 7.47x | 7.17x | 4.94x | 5.02x | 4.47x | 4.12x |
| EV / Revenue | 13.7x | 8.53x | 7.38x | 7x | 4.73x | 4.78x | 4.22x | 3.83x |
| EV / EBITDA | 39.6x | 27.5x | 24.2x | 23.2x | 14.9x | 16.3x | 13.2x | 11.7x |
| EV / EBIT | 47.7x | 34.5x | 29.9x | 28.5x | 17.8x | 20.9x | 16.5x | 14.3x |
| EV / FCF | 68x | 81.1x | 45.1x | 41.4x | 31.4x | 34.4x | 32.7x | 25.9x |
| FCF Yield | 1.47% | 1.23% | 2.22% | 2.42% | 3.19% | 2.91% | 3.06% | 3.86% |
| Dividend per Share 2 | 2 | 2 | 2.25 | 2.5 | 2.75 | 2.75 | 3.133 | 3.4 |
| Rate of return | 0.62% | 0.87% | 1.06% | 1.15% | 1.75% | 1.69% | 1.92% | 2.08% |
| EPS 2 | 5.25 | 4.96 | 5.46 | 5.9 | 6.42 | 5.831 | 7.313 | 8.294 |
| Distribution rate | 38.1% | 40.3% | 41.2% | 42.4% | 42.8% | 47.2% | 42.8% | 41% |
| Net sales 1 | 565.6 | 639.3 | 677.3 | 723.2 | 759 | 775.1 | 870 | 944.7 |
| EBITDA 1 | 196.2 | 198.4 | 206.8 | 218.7 | 241.4 | 227.3 | 277.7 | 309.5 |
| EBIT 1 | 162.7 | 158.3 | 167.1 | 177.7 | 202.1 | 177.5 | 222.9 | 253.3 |
| Net income 1 | 125.3 | 118.3 | 130.3 | 140.7 | 153.1 | 139 | 174.4 | 197.7 |
| Net Debt 1 | 6.368 | -5.558 | -56.94 | -122.6 | -162.6 | -187.5 | -221.9 | -278.4 |
| Reference price 2 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 | 163.20 | 163.20 | 163.20 |
| Nbr of stocks (in thousands) | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | - | - |
| Announcement Date | 04/02/22 | 08/02/23 | 07/02/24 | 06/02/25 | 05/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.99x | 4.78x | 16.3x | 1.68% | 395M | |
| 64.84x | 5.1x | 17.04x | 0.32% | 17.65B | |
| 43.54x | - | - | 1.86% | 1.89B | |
| 14.81x | 2.02x | 6.86x | 1.73% | 870M | |
| 39.34x | - | - | - | 779M | |
| -2.58x | 1.35x | 6.26x | - | 728M | |
| 113.43x | - | - | 1.03% | 555M | |
| -10.72x | - | - | - | 436M | |
| 32.9x | 2.82x | 16.8x | -.--% | 439M | |
| Average | 35.95x | 3.21x | 12.65x | 1.11% | 2.64B | |
| Weighted average by Cap. | 56.96x | 4.77x | 16.19x | 0.55% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CEVI Stock
- Valuation CellaVision AB
Select your edition
All financial news and data tailored to specific country editions
